Improving Hypertension _ Diabetes Control and Prevention
An e-NEWSLETTER from Quality Insights                                                                             September 22, 2017

In This Issue

reporting dates to remember:


IPPSruleThe IPPS Final Rule will be effective on October 1, 2017.  The Medical Assistance Provider Incentive Repository (MAPIR) system will be unavailable to accept program year 2017 applications while the new requirements are incorporated into MAPIR. It is anticipated that program year 2017 applications will be available, after the updates, by November 1, 2017.

The IPPS Rule includes changes made to Clinical Quality Measure (CQM) reporting. For eligible providers (EPs), there will now be 53 CQMs instead of 64 CQMs. EPs only need to attest to six (6) CQMs and there are no domain requirements so the CQMs do not need to fall within three (3) different domains. Finally, the CQM reporting period has changed to any continuous 90-day period for all EPs.

IPPS Final Rule
focused ce series offers s PANISH FOR HEALTHCARE PROVIDERS course 

Course Available: October 9 - November 22, 2017
20% OFF Coupon Code: SpanishOct20Percent
Contact Hours: 12.0

spanishThe Spanish for Healthcare Providers Focused CE Series will teach you to confidently and effectively communicate medical terms and phrases to your Spanish-speaking patients.

  • Language and cultural considerations when communicating with Spanish-speaking patients with limited English
  • Basic Spanish phrases needed to communicate with Spanish-speaking patients in your role as a healthcare professional
  • Assessment questions that stimulate a one-word or yes-no response from patients
  • How to interpret patient responses in Spanish
  • How to communicate test results in Spanish
  • How to explain treatment procedures in Spanish
  • Basic phrases and commands to complete a physical exam
  • Increased communication with your Spanish-speaking patients as soon as your next shift
  • More independence in your day-to-day interactions with your Spanish-speaking patients
  • Expand your knowledge of Spanish to improve patient care
did you know that The Prescription Drug Monitoring Program Is Now a Specialized Registry? 

pills drugsEffective September 1, 2017, the Prescription Drug Monitoring Program (PDMP) is now considered a specialized registry. Providers can use it for program year 2017 applications as long as their Meaningful Use reporting period is September 1st or later. The PDMP project to integrate with the Electronic Health Records and Pharmacy Management Systems for eligible health care entities is underway. Visit the Department of Health Integration web page to find out more.
If you have any questions/comments about the Medical Assistance (MA) EHR Incentive Program and the PDMP, please send an email to and put " PDMP Question" in the subject line.
learn about the ada's position statement on the assessment & treatment of hypertension in patients with diabetes 

blood pressure articleA recent Clinical Advisor article,  Managing Hypertension in Diabetes: A Position Statement from the ADA, focuses on the release of a position statement from t he American Diabetes Association (ADA) to update the assessment and treatment of hypertension among patients with diabetes. 

According to the article, the position statement was published in Diabetes Care and includes advances in care since the ADA last published a statement on this topic in 2003. The ADA noted that antihypertensive therapy is shown to reduce atherosclerotic cardiovascular disease (ASCVD) events, heart failure, and microvascular complications in patients with diabetes. There have also been reductions in ASCVD morbidity and mortality in patients with diabetes since 1990, which are likely due to improvements in blood pressure control.

"Treatment should be individualized to the specific patient based on their comorbidities; their anticipated benefit for reduction in ASCVD, heart failure, progressive diabetic kidney disease, and retinopathy events; and their risk of adverse events," noted the ADA in its position statement. "This conversation should be part of a shared decision-making process between the clinician and the individual patient."

The ADA has made the following recommendations for screening and diagnosis:
  • Clinicians should measure blood pressure at every routine clinical care visit. Patients with elevated blood pressure ≥140/90 mmHg should have blood pressure confirmed with multiple readings to diagnose hypertension (Grade B recommendation).
  • Hypertensive patients with diabetes should have home blood pressure monitoring to identify white-coat hypertension (Grade B recommendation).
  • Orthostatic measurement of blood pressure should be performed during initial evaluation of hypertension and periodically at follow-up, or when symptoms of orthostatic hypotension are present, and regularly if orthostatic hypotension has been diagnosed (Grade E recommendation).
To read the entire article, please click here.
contact information

For more details about the Improving Hypertension and Diabetes Care & Prevention project, please contact Rhonda Dodson.
Quality Insights logo
Funding provided by the Pennsylvania Department of Health through the State Public Health Actions to Prevent and Control 
Diabetes,  Heart Disease, Obesity and Associated Risk Factors and Promote School Health federal grant from the Centers for 
Disease Control  and Prevention. Publication number: PADOH-HD-092217